T. ROWE PRICE INVESTMENT MANAGEMENT, INC. Apellis Pharmaceuticals, Inc. Transaction History

T. ROWE PRICE INVESTMENT MANAGEMENT, INC. portfolio value:

$376.75M
portfolio value

Apellis Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 5.51M shares 376.75M $68.3 5.51M